Political appointees under President Donald Trump are reportedly directing the National Institutes of Health to flag and freeze grant applications focused on public policy [1, 2].
This move targets the intersection of scientific research and governance. By restricting funds for studies that inform policymakers, the administration may alter how public health legislation is developed and supported in the U.S.
The reports indicate that the freeze specifically affects applications whose primary function is to inform legislators and policymakers about the health effects of public policy [2]. This directive comes as the administration seeks to refine the scope of federally funded research at the NIH [1, 2].
Under the current guidance, research that provides the evidentiary basis for policy changes is being flagged for review [1]. The process involves identifying grants that bridge the gap between clinical or laboratory findings and the legislative process, a practice that has historically guided public health mandates.
The National Institutes of Health is the primary agency for biomedical and public health research in the U.S. [1]. The flagging of these grants suggests a shift in how the agency views the role of science in the political sphere [2].
While the administration has not released a formal public statement on the specific criteria for these freezes, the reports suggest a concerted effort to limit the influence of federally funded research on the legislative agenda [1, 2].
“Political appointees are flagging and freezing grant applications that focus on informing policy makers.”
This shift indicates a move toward decoupling federal scientific funding from policy advocacy. By restricting research designed to influence legislation, the administration is effectively limiting the academic evidence available to lawmakers, which could change the trajectory of public health regulations and the way the U.S. government justifies health-related laws.
